Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

All Specialties

OpiCalc Logo
FavoritesSpecialtiesDrugsGuidelinesMost Used
FavesSpecsDrugsGuidesTop
BED Calculator (Biological Effective Dose)DS-GPA Score (Diagnosis-Specific GPA)EQD2 Calculator (Equivalent Dose in 2Gy)GPA Score (Graded Prognostic Assessment)Iso-effective Dose ConverterNSD Calculator (Ellis Formula)RPA Grading for Brain MetastasesRadiation Necrosis MRI IndexSRS Dose Selection (RTOG)TDF Factor (Time-Dose-Fractionation)
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2018-2026

•

All Rights Reserved

In Recent Clinical News

Scanning Medical Journals

No new significant updates or guidelines matching this topic were found today. We will check again soon.

Radiation Oncology

TDF Factor (Time-Dose-Fractionation)

Radiobiology History: TDF Factor

Regimen Details

*Note units in cGy (1 Gy = 100 cGy)

Historical Context Mode

Calculate the TDF factor to compare current plans with legacy 1970s-1990s radiation oncology protocols.

Guidelines & Evidence

Verified

Last Review: 2026

History & Concept

Origin of TDF

The TDF system was developed by Orton and Ellis in 1973 as a practical clinical tool to simplify the Nominal Standard Dose (NSD) equation. It was designed to allow clinicians to easily add together the biological effects of different treatment phases. While largely superseded by the BED (Linear-Quadratic model) in modern practice, it remains a valuable reference for historical data and some long-term clinical trial analysis.

The TDF Equation

$$TDF = n imes d^{1.538} imes X^{-0.169} imes 10^{-3}$$ Where: n = number of fractions, d = dose per fraction (cGy), X = fractionation interval (days per week factor).

Last Comprehensive Review: 2026